Three things to know:
1. Ossifix develops implants from high-density, allograft cortical bone.
2. Umbra and Ossifix are working to create biodegradable polymer-based surgical instrumentation featuring antimicrobial technology.
3. CEO Alex Umbra said the transaction is part of the company’s “growth through acquisition approach,” which will expand its reach in orthopedics.
More articles on devices:
The most controversial trends in spine from 10 surgeons
6 Texas orthopedic practices to merge into 150-plus physician group
We’re going to need a bigger scalpel — Mississippi spine surgeon operates on sand tiger shark’s spine
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
